This site is intended for healthcare professionals only

In association with the Cardiorenal Forum

Articles

  • Man taking pill with water

    Dapagliflozin and cardiovascular risks with worsening renal function

  • Rack of blood sample tubes

    Cardiorenal biomarkers in the CREDENCE trial

  • Inhibition of the renin–angiotensin–aldosterone system in early chronic kidney disease: do we know as much as we think we do?

  • Benefits and harms of RAAS inhibition in adults with early chronic kidney disease

  • CRIC study: Chronic kidney disease progression after acute kidney injury

  • RAAS inhibition combinations and risk of acute kidney injury and hyperkalaemia in diabetic kidney disease

  • Longitudinal B-type natriuretic peptide monitoring and kidney failure

  • Serum potassium and risk of death or kidney replacement therapy in older patients with advanced CKD

  • Low and high potassium levels associated with harm in older people with chronic kidney disease

alt

For the latest news and articles
Sign up to Renal Review newsletters

Subscribe